跳至主要内容
临床试验/NCT07374835
NCT07374835Enrolling By Invitation不适用

BMI Stratified Management Based on Meridian-Lymph Axis Theory for Lower Extremity Lymphedema in Patients After Gynecologic Cancer Surgery

Hong Zhang1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年10月9日最近更新:
干预措施

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
入组人数
60
试验地点
1
主要终点
Change in Lower Extremity Lymphedema Volume (Measured by Circumferential Method)

研究概览

简要总结

This study aims to investigate the impact of a BMI-stratified intervention program based on the meridian-lymphatic axis theory on the incidence of lower extremity lymphedema in postoperative patients with gynecological malignant tumors at 1 month, 3 months, and 6 months, and to validate the precision and effectiveness of this program compared to traditional CDT. Primary objectives: to evaluate the effects of this program on reducing the incidence of lymphedema, alleviating lymphedema-related symptoms (assessed via GCLQ score), improving patients' quality of life (assessed via LLQoL score), and enhancing patients' self-management behaviors.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Female patients aged 18-75 years who have undergone gynecologic cancer surgery (including hysterectomy, oophorectomy, or lymphadenectomy).
  • Diagnosed with lower extremity lymphedema (stage I-II) within 6 months to 2 years post-surgery, confirmed by circumferential measurement.
  • BMI between 18.5 and 35.0 kg/m². Able to understand and sign the informed consent form, and comply with the intervention and follow-up schedule.
  • No history of severe cardiovascular, renal, or hepatic dysfunction that would interfere with study participation.

排除标准

  • Patients with lower extremity lymphedema caused by other etiologies (e.g., trauma, infection, or congenital lymphedema).
  • History of lower extremity surgery or fracture within 3 months prior to enrollment.
  • Active infection or skin ulceration in the affected lower extremity. Participation in other clinical trials involving lymphedema interventions within the past 3 months.
  • Pregnancy or lactation during the study period. Inability to complete the intervention or follow-up due to cognitive or mobility impairment.

研究组 & 干预措施

BMI Stratified Management Group

Experimental

Participants receive personalized management based on BMI, combining meridian conditioning and lymphatic circulation interventions.

干预措施: Meridian-Lymph Axis Based BMI Stratified Management (Other)

Routine Care Control Group

Other

Participants receive standard lymphatic edema care (e.g., compression garments, basic exercise guidance).

干预措施: Routine Lymphatic Edema Care (Other)

结局指标

主要结局

Change in Lower Extremity Lymphedema Volume (Measured by Circumferential Method)

时间窗: Baseline (before intervention), 12 weeks after intervention initiation

Limb volume change will be calculated using circumferential measurements of the lower extremity (ankle, calf, thigh) to quantify the reduction in lymphedema severity after intervention.

Change in Lower Extremity Lymphedema Volume (measured by circumferential measurement) from baseline to 12 weeks after intervention

时间窗: Baseline, 12 weeks

Limb volume change will be calculated using circumferential measurements of the lower extremity to assess the efficacy of the intervention in reducing lymphedema.

次要结局

  • Change in Limb Function Score (using the Lymphoedema Functioning, Disability and Health Questionnaire, LYMPH-Q) from baseline to 12 weeks(baseline to 12 weeks)
  • Change in Quality of Life Score (using the European Organization for Research and Treatment of Cancer QLQ-C30) from baseline to 12 weeks(baseline to 12 weeks)

研究者

发起方
Hong Zhang
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Hong Zhang

Associate Chief Nurse

Tongji Hospital

研究点 (1)

Loading locations...

相似试验